Obtain mechanistic understanding and novel insights into disease biology.

Speed up

Speed up your early R&D process and reduce your time-to-decision making.


Identify targets and lead compounds with potential to produce first-in-class medicines.
Our services

An approach you can trust

We are seasoned specialists in providing neurobiology research services. Our mission is to create groundbreaking in vitro concepts that will advance the neuroscience research field and enable our Clients to conduct successful drug discovery programs.
Read more arrow_forward

Basic research

From dechipering disease mechanisms to exploration of novel assay concepts.

Target discovery

Using functional genomics and advanced in vitro models we help our Clients to identify and validate novel targets.

Lead discovery

Phenotypic and target-based assay development, screening and lead optimization.
Our platform

Elevated neurobiology in vitro research

What sets us apart from the competition is our unique discovery platform. By combining drug discovery expertise and disease area knowledge with cutting-edge technologies, we are creating complex disease models and assays for functional and morphological screening.
Read more arrow_forward

News and events

Latest news and insights

Cellectricon values scientific exchange and we invite you to take part of our latest news and to learn about upcoming events.

Read more

March 28 - April 1, 2023
AD/PD 2023
The AD/PD 2023 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders takes place in Gothenburg, Sweden on...
Social Media
Delix Therapeutics partners with Cellectricon, Expressive Neuroscience and expands science team to accelerate drug discovery and translatability
We’re excited to be working with Delix Therapeutics and support their development of neuroplasticity-promoting therapeutics! At Cellectricon, we solve our...
Cellectricon strengthens IP portfolio – Receives “Intention to Grant” from the European Patent Office
Cellectricon AB, a leading provider of neurobiology in vitro research services, today announced that the company received notice of intention...
November 12-16, 2022
Neuroscience 2022
The Neuroscience 2022 meeeting takes place in San Diego on November 12-16. During the conference, we will present several posters...
September 29, 2022
Webcast - Validation of an in vitro α-synuclein aggregation assay for target discovery in neurodegenerative disease research
Event info: In this webcast, Paul Karila, Head of Drug Discovery, and Johan Pihl, Chief Operating Officer, discuss the development...
September 19-23, 2022
World Congress on Pain
The IASP 2022 World Congress on Pain takes place in Toronto, Canada and online on September 19-23, 2022. At the...
Social Media
Poster presentation at Advances in Cell-based Screening meeting
Missed Cellectricon at the ELRIG meeting on Advances in Cell-based Screening? There is still a chance to receive a copy...
Social Media
BonePain II consortium annual meeting
A great day for networking when the BonePain II consortium convenes in lovely Cambridge! The members of the BonePain II...
Cellectricon receives funding from Takeda’s open innovation platform
Cellectricon, a leading provider of neurobiology in vitro research services, is delighted to announce the initiation of a new research...

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy